New study tracks how postpartum depression symptoms change with zuranolone
NCT ID NCT07398469
First seen Feb 28, 2026 · Last updated Jun 22, 2026 · Updated 14 times
Summary
This observational study follows 200 people with postpartum depression who are starting zuranolone (Zurzuvae). Participants complete online surveys about their symptoms at 15, 45, and 90 days after their first dose. The goal is to see how symptoms change over time in real-world use, without changing their medical care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTPARTUM DEPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Biogen
RECRUITINGCambridge, Massachusetts, 02142, United States
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
zuranolone (Zurzuvae)
What this could lead to
If successful, this study could provide real-world evidence on how well zuranolone works for postpartum depression in everyday settings.
What could go wrong
This is an observational study, not a controlled trial, so results may be influenced by factors other than the drug. It is also relatively small and short-term.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.